We have the lab up and running! Looking to recruit a post-doc to join us in the “D”. Applicants interested in metabolic disease research with an inkling towards using imaging approaches to study lipid metabolism. https://t.co/tY0PWMHAyC DM @Mottillo_Lab Please RT. Thanks!
The tragic transition of 🇨🇦 from fighting alongside 🇺🇸 in 2 world wars and in Afghanistan, rescuing American hostages in Iran, working collaboratively with our American neighbours across a spectrum of endeavours, now waking up with sadness to a new economic declaration of war 💔
Finally, LD targeting of PNPLA3 I148M is required to promote steatosis in vivo. Overall, data suggest a critical role for PNPLA3 I148M - LD localization to sequester ABHD5 and promote steatosis.
Our JBC paper is now online! Here we examine the mechanisms by which a common genetic variant in PNPLA3 (148M) causes fatty liver disease and builds upon our previous work on the interaction of PNPLA3 with ABHD5.
https://t.co/mI3tf1J6hY
Had a great time in Munich at the Helmholtz Diabetes conference. It was an honor to be nominated for the HeIDi Young Investigator award and present our work. Wonderful meeting all the new people and connecting again with colleagues!
https://t.co/IXo0MM6uSf
Let the games begin! 🎉
The 11th Helmholtz Diabetes Conference has officially begun! Stephan Herzig just opened the event, and we’re very excited for the next 3 days full of cutting-edge research focusing on wasting metabolism! 🙌
#HelmholtzDiabetes2024
Our paper is now online! Here we investigate the direct effect of lipolysis on AMPK signaling in adipocytes. Using our real-time FRET sensor we show lipolysis genereates long-chain acyl-CoAs that are involved in allosteric activation of AMPK.#lipidtime
https://t.co/ozdqOHRWNw
Congrats to Dr. Emilio Mottillo who was recently notified he has been promoted to Associate Professor (Research) FTA in Physiology effective August 2024!